GASTROESOPHAGEAL CANCER
Clinical trials for GASTROESOPHAGEAL CANCER explained in plain language.
Never miss a new study
Get alerted when new GASTROESOPHAGEAL CANCER trials appear
Sign up with your email to follow new studies for GASTROESOPHAGEAL CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Experimental drug tested for Tough-to-Treat cancers
Disease control TerminatedThis early-phase study tested a new drug called PRO1107 in patients with advanced solid tumors that had stopped responding to other treatments. The main goals were to find a safe dose and see if the drug could shrink tumors in cancers like ovarian, lung, breast, and others. The s…
Matched conditions: GASTROESOPHAGEAL CANCER
Phase: PHASE1, PHASE2 • Sponsor: Genmab • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC
-
New drug combo tested in fight against advanced stomach cancer
Disease control TerminatedThis study tested whether adding an experimental drug called DKN-01 to a standard immunotherapy (tislelizumab) and chemotherapy could better control advanced stomach or gastroesophageal cancer. It involved about 247 adults whose cancer could not be removed by surgery. The main go…
Matched conditions: GASTROESOPHAGEAL CANCER
Phase: PHASE2 • Sponsor: Leap Therapeutics, Inc. • Aim: Disease control
Last updated Mar 18, 2026 14:41 UTC